Mindray Medical International, a Chinese medical device manufacturer based in Shenzhen China, showcased its latest innovations at the 75th China International Medical Equipment Fair (CMEF) from April 17 to 20 at the National Exhibition and Convention Centre in Shanghai. Celebrating the 25th anniversary since its foundation in 1991, Mindray launched new products from all three key business lines, namely Patient Monitoring and Life Support, In-vitro Diagnostics and Medical Imaging System.
Mindray’s first wearable medical device, Mr. Wear Wearable ECG Recorder/Bluetooth Heart Rate Monitor, was officially released to China’s domestic market at the exhibition. Combining Mindray’s expertise in ECG solutions and state-of-the-art industrial design, Mr. Wear is one of the lightest and thinnest ECG recorder on the market. It can be applied in chronic disease management and postoperative recovery for patients as well as in health and fitness management for the healthy.
Stryker announced that it has acquired Stanmore Implants Worldwide Limited from SIW Holdings Limited in an all cash transaction for £35.6 million. Stanmore Implants is an innovative orthopaedic business focused on serving the needs of surgeons that treat adult and juvenile orthopaedic oncology. Stanmore Implants’ portfolio includes both patient specific and off-the-shelf implant systems aimed at limb salvage.
“The acquisition of Stanmore Implants provides Stryker with differentiated technologies designed to provide the most effective solutions for orthopaedic oncology surgeons. This addition underscores Stryker’s commitment to our core joint replacement business and expands our presence in the global orthopaedic oncology market,” said David Floyd, Group President, Stryker Orthopaedics.
“The combination of Stryker’s commitment to orthopaedic oncology and Stanmore’s novel orthopaedic oncology solutions provides a unique opportunity to impact a broader group of patients globally,” said Michael Mainelli, Chief Executive Officer, Stanmore Implants.